Wird geladen...

Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

Cancer immunotherapy has altered the management of human malignancies, improving outcomes in an expanding list of diseases. Breast cancer - presumably due to its perceived low immunogenicity - is a late addition to this list. Furthermore, most of the focus has been on the triple negative subtype bec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Chrétien, Sebastian, Zerdes, Ioannis, Bergh, Jonas, Matikas, Alexios, Foukakis, Theodoros
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562626/
https://ncbi.nlm.nih.gov/pubmed/31060337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050628
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!